The full application for Cohort 3 will run from January 3, 2023 through May 12, 2023. The application, which includes all required and supplemental application documents, must be submitted electronically through the Application Portal. The application deadline is May 12, 2023 at 11:59 PM ET. Incomplete applications and late submissions will not be accepted.
The application review and selection process will take place from May 13, 2023 through early August 2023. Each application will be reviewed by at least two members of the Winn CDA Review Panel. Final selections will be recommended by the Winn CDA Selection Committee and officially approved by the Executive Committee. Award notifications will take place in early August 2023, which will initiate the official contracting/ award agreement process. The public announcement of the Winn CDA Cohort 3 scholars will take place in early-October 2023. The Winn CDA Cohort 3 will kick-off in mid-October 2023.
If you have any questions, please email the Winn CDA team.
In determining eligible candidates for the Robert A. Winn Career Development Award (Winn CDA) program, the following racial/ethnic groups are designated as "underrepresented in medicine”:
OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.
Citizenship or immigration status
Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B and O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]
Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD
Eligible candidates will be Early-Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies - whichever date is later - within the past 10 years and have not yet competed successfully for substantial NIH research grants. (Applicants with an RO1 or RO1 equivalent are ineligible.)
Jan 3, 2023
May 12, 2023
May 15 - Aug 1, 2023
Aug 2, 2023
Cohort 3 Begins:
Note: Dates are subject to change.